<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commentaires sur : FIREFISH 2-year data show continued benefit of risdiplam for type 1 SMA	</title>
	<atom:link href="https://institut-servier.com/fr/firefish-2-year-data-show-continued-benefit-of-risdiplam-for-type-1-sma/feed/" rel="self" type="application/rss+xml" />
	<link>https://institut-servier.com/fr/firefish-2-year-data-show-continued-benefit-of-risdiplam-for-type-1-sma/</link>
	<description>L’Institut Servier est une association loi 1901 dont le but est de promouvoir la recherche et le progrès de la médecine</description>
	<lastBuildDate>Tue, 03 Jan 2023 14:18:49 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
